---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-006405"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:53:31.590175+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro stockholders approve reverse stock split and Series C conversion at annual meeting

## Summary
- Elected eight directors including William B. Horne, Milton C. Ault III, and others with substantial support; broker non-votes of 2,270,160.
- Ratified Haskell & White LLP as independent auditor for fiscal year ending April 30, 2025; 4,255,027 for, 54,999 against.
- Approved conversion of Series C Preferred Stock into common and warrants for up to $5M (less 5% discount); 757,391 for, 142,345 against.
- Approved reverse stock split at ratio between 1:2 and 1:10, board to set exact ratio by April 24, 2026; 3,252,166 for, 1,077,493 against.

## SEC filing metadata
- accession: 0001214659-25-006405
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925006405/0001214659-25-006405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925006405/i4252528k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-006405
- JSON: https://secwatch.observer/filing/0001214659-25-006405.json
- Plain text: https://secwatch.observer/filing/0001214659-25-006405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.